Back to search results

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Abroad (travel likely)RecruitingPHASE3

Conditions

Esophageal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Providence Medical Foundation, Fullerton, California, United States

  • Henry Ford Health System, Detroit, Michigan, United States

  • Baptist Cancer Center, Memphis, Tennessee, United States

  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • John Peter Smith Hospital, Fort Worth, Texas, United States

  • Virginia Cancer Specialists, Fairfax, Virginia, United States

  • Institut Jules Bordet, Brussels, Belgium

  • Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • Antwerp University Hospital, Edegem, Belgium

  • UZ Leuven, Leuven, Belgium

  • Anyang Cancer Hospital, Anyang, China

  • Beijing Cancer Hospital, Beijing, China

  • Jilin Cancer Hospital, Changchun, China

  • Changzhou Cancer Hospital, Changzhou, China

  • Sichuan cancer hospital, Chengdu, China

  • West China Hospital Sichuan University, Chengdu, China

  • Fujian Cancer Hospital, Fuzhou, China

  • Harbin Medical University Cancer Hospital, Harbin, China

  • The First Affiliated Hospital of Fujian Medical University, Hefei, China

  • Jinan Central Hospital, Jinan, China

  • Shandong Cancer Hospital, Jinan, China

  • Affiliated Hospital of Jining Medical University, Jining, China

  • Guangxi Medical University Affiliated Tumor Hospital, Nanning, China

  • Liaoning Cancer Hospital and Institute, Shenyang, China

  • Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

  • The First Affiliated Hospital of Xinxiang Medical University, Weihui, China

  • Hubei Cancer Hospital, Wuhan, China

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China

  • Zhongshan Hospital Xiamen University, Xiamen, China

  • Subei Peoples Hospital, Yangzhou, China

  • Sainte Catherine Institut du cancer Avignon en Provence, Avignon, France

  • CHU Brest - Hôpital de la Cavale Blanche, Brest, France

  • Institut Régional du Cancer de Montpellier, Montpellier, France

  • Hôpital Européen Georges Pompidou, Paris, France

  • CHU Poitiers - Hôpital la Milétrie, Poitiers, France

  • Unité de recherche clinique ICANS, Strasbourg, France

  • CHU Toulouse Rangueil Service dOncologie médicale, Toulouse, France

  • Krankenhaus Nordwest GmbH, Frankfurt am Main, Germany

  • Hämatologisch Onkologische Praxis Eppendorf HOPE, Hamburg, Germany

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Azienda Ospedaliera Universitaria Luigi Vanvitelli, Naples, Italy

  • IOV - Istituto Oncologico Veneto IRCCS, Padova, Italy

  • Fondazione Policlinico Gemelli, Rome, Italy

  • National Cancer Center Hospital, Chūōku, Japan

  • Hiroshima University Hospital, Hiroshima, Japan

  • National Cancer Center Hospital East, Kashiwa, Japan

  • Kagawa University Hospital, Kita-gun, Japan

  • Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan

  • Cancer Institute Hospital of JFCR, Kōtoku, Japan

  • Shikoku Cancer Center, Matsuyama, Japan

  • Aichi Cancer Center, Nagoya, Japan

  • Osaka International Cancer Institute, Osaka, Japan

  • Kindai University Hospital, Ōsaka-sayama, Japan

  • Saitama Cancer Center, Saitama, Japan

  • Hokkaido University Hospital, Sapporo, Japan

  • SHOWA Medical University Hospital, Shinagawa-ku, Japan

  • Keio University Hospital, Shinjuku-ku, Japan

  • The University of Osaka Hospital, Suita-shi, Japan

  • Shizuoka Cancer Center, Sunto-gun, Japan

  • Kanagawa Cancer Center, Yokohama, Japan

  • Erasmus MC, Rotterdam, Netherlands

  • Zanamed Medical Clinic Sp z o o, Lublin, Poland

  • Mazowiecki Szpital Wojewódzki, Siedlce, Poland

  • Memorial Healthcare International S R L, Bucharest, Romania

  • S.C Radiotherapy Center Cluj S.R.L, Comuna Floresti, Romania

  • Centrul de Oncologie Sfantul Nectarie Craiova, Craiova, Romania

  • S.C. Sigmedical Services SRL, Suceava, Romania

  • Kyungpook National University Chilgok Hospital, Daegu, South Korea

  • National Cancer Center, Goyang-sisouth, South Korea

  • Chonnam National University Hwasun Hospital, Hwasun-gun, South Korea

  • Gachon University Gil Medical Center, Incheon, South Korea

  • Seoul National University Bundang Hospital, Seongnam-si, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • Asan Medical Center, Seoul, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • The Catholic University of Korea, Seoul St. Marys Hospital, Seoul, South Korea

  • Korea University Guro Hospital, Seoul, South Korea

  • Hospital Universitario de Burgos, Burgos, Spain

  • Hospital General Universitario de Elche, Elche, Spain

  • Hospital Univ Regional de Málaga Hosp Civil, Málaga, Spain

  • Complejo Hospitalario Universitario de Orense, Ourense, Spain

  • Hospital Universitario de Navarra, Pamplona, Spain

  • Hospital Universitario Virgen Macarena, Seville, Spain

  • Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan

  • China Medical University Hospital, Taichung, Taiwan

  • National Cheng Kung University Hospital, Tainan, Taiwan

  • National Taiwan University Hospital, Taipei, Taiwan

  • Taipei Veterans General Hospital, Taipei, Taiwan

View source on ClinicalTrials.gov(opens in a new tab)